These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6119935)

  • 1. [Correction of cardiovascular hypodynamics in the early postoperative period with the adrenergic beta receptor agonist acrinor].
    Dubova MN
    Anesteziol Reanimatol; 1981; (5):21-4. PubMed ID: 6119935
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological aspects on the treatment of CHF.
    Andersson KE
    Acta Med Scand Suppl; 1981; 652():69-91. PubMed ID: 6120616
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation using dynamic ECG of the effects of reproterol (a new beta-2 adrenergic receptor agonist) on the heart conduction system].
    Citone C; Carelli M; Di Marcotullio G; Tubaro M; Milazzotto F
    Clin Ter; 1984 Sep; 110(5):429-36. PubMed ID: 6149836
    [No Abstract]   [Full Text] [Related]  

  • 4. Inotropic drugs for treatment of the failing heart.
    Maskin CS; Le Jemtel TH; Sonnenblick EH
    Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of beta3-adrenergic receptor agonists in the treatment of heart failure.
    Rasmussen HH; Figtree GA; Krum H; Bundgaard H
    Curr Opin Investig Drugs; 2009 Sep; 10(9):955-62. PubMed ID: 19705338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
    Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
    Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the beta 1-adrenergic receptor partial agonist xamoterol on left ventricular diastolic function. An evaluation after 1-6 years of oral therapy.
    Pouleur H; Etienne J; Van Mechelen H; Gurné O; Rousseau MF
    Circulation; 1990 Feb; 81(2 Suppl):III87-92. PubMed ID: 1967560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term effect of a new beta-agonist prenalterol in patients with severe congestive heart failure (author's transl)].
    Lambertz H; Erbel R; Meyer J; Schweizer P; Effert S
    Z Kardiol; 1982 Jan; 71(2):65-74. PubMed ID: 6122313
    [No Abstract]   [Full Text] [Related]  

  • 9. [The value of xamoterol in moderate ischemic cardiac insufficiency].
    Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
    Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiopathology and treatment of cardiac insufficiency in the acute stage of infarct].
    Perret C
    Schweiz Med Wochenschr; 1981 Jun; 111(26):965-76. PubMed ID: 6115465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of beta-blocking agents and beta stimulators on the intracardiac hemodynamics and myocardial contraction in ischemic heart disease].
    At'kov OIu; Krol VA; Chumburidze VB
    Ter Arkh; 1977; 49(10):57-60. PubMed ID: 22937
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias.
    Canepa-Anson R; Dawson JR; Frankl WS; Kuan P; Sutton GC; Reuben S; Poole-Wilson PA
    Eur Heart J; 1982 Dec; 3 Suppl D():129-34. PubMed ID: 6130946
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of beta-1-adrenergic agonists in the treatment of cardiac insufficiency].
    Coulombe D
    Ann Cardiol Angeiol (Paris); 1984; 33(4):207-10. PubMed ID: 6147113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New drugs with positive inotropic action].
    Bijak A; Czołpiński T
    Kardiol Pol; 1982; 25(4):357-65. PubMed ID: 6128439
    [No Abstract]   [Full Text] [Related]  

  • 15. Review: therapeutic concepts of congestive heart failure.
    Haustein KO
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):273-81. PubMed ID: 1974888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure].
    Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
    Kokyu To Junkan; 1988 Nov; 36(11):1227-33. PubMed ID: 2907820
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adrenergic signal transduction in heart failure].
    Ahlquist P
    Ugeskr Laeger; 1992 Aug; 154(33):2251-4. PubMed ID: 1357801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
    Lee HR; Hershberger RE; Port JD; Rasmussen R; Renlund DG; O'Connell JB; Gilbert EM; Mealey PC; Volkman K; Menlove R
    J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic cardiac failure in noncoronarogenic myocardial diseases and refracterin effects].
    Paleev NR; Sanina NP; Paleev FN; Pronina VP; Sukoian GV; Karsanov NV
    Klin Med (Mosk); 1998; 76(6):21-6. PubMed ID: 9693495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.